These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 31189630

  • 1. Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.
    Liu S, Singer A, McAlister FA, Peeler W, Heran BS, Drummond N, Manca DP, Allan GM, Korownyk C, Kolber MR, Greiver M, Garrison SR.
    Can Fam Physician; 2019 Jun; 65(6):416-425. PubMed ID: 31189630
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
    Pokorney SD, Simon DN, Thomas L, Fonarow GC, Kowey PR, Chang P, Singer DE, Ansell J, Blanco RG, Gersh B, Mahaffey KW, Hylek EM, Go AS, Piccini JP, Peterson ED, Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators.
    Am Heart J; 2015 Jul; 170(1):141-8, 148.e1. PubMed ID: 26093875
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F, Renlund H, Lip GY, Wester P, Svensson PJ, Själander A.
    JAMA Cardiol; 2016 May 01; 1(2):172-80. PubMed ID: 27437888
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Warfarin for atrial fibrillation in community-based practise.
    Rose AJ, Ozonoff A, Henault LE, Hylek EM.
    J Thromb Haemost; 2008 Oct 01; 6(10):1647-54. PubMed ID: 18853483
    [Abstract] [Full Text] [Related]

  • 8. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
    Singer DE, Hellkamp AS, Piccini JP, Mahaffey KW, Lokhnygina Y, Pan G, Halperin JL, Becker RC, Breithardt G, Hankey GJ, Hacke W, Nessel CC, Patel MR, Califf RM, Fox KA, ROCKET AF Investigators.
    J Am Heart Assoc; 2013 Feb 19; 2(1):e000067. PubMed ID: 23525418
    [Abstract] [Full Text] [Related]

  • 9. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.
    Apostolakis S, Sullivan RM, Olshansky B, Lip GYH.
    Chest; 2013 Nov 19; 144(5):1555-1563. PubMed ID: 23669885
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting.
    Han SY, Palmeri ST, Broderick SH, Hasselblad V, Rendall D, Stevens S, Tenaglia A, Velazquez E, Whellan D, Wagner G, Heitner JF.
    J Electrocardiol; 2013 Nov 19; 46(1):45-50. PubMed ID: 23063241
    [Abstract] [Full Text] [Related]

  • 13. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.
    Macedo AF, Bell J, McCarron C, Conroy R, Richardson J, Scowcroft A, Sunderland T, Rotheram N.
    Thromb Res; 2015 Aug 19; 136(2):250-60. PubMed ID: 26073321
    [Abstract] [Full Text] [Related]

  • 14. Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada.
    McAlister FA, Wiebe N, Hemmelgarn BR.
    BMJ Open; 2018 Jan 29; 8(1):e016980. PubMed ID: 29382672
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation.
    Yasaka M, Minematsu K, Yamaguchi T.
    Intern Med; 2001 Dec 29; 40(12):1183-8. PubMed ID: 11813841
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.